1243. Semi-Quantitative Benefit-Risk Assessment for a New Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Individuals 2 Years of Age and Older

BACKGROUND: MenACYW-TT is a new quadrivalent meningococcal conjugate vaccine approved by the US FDA for use in individuals 2 years and older. We present the structured benefit-risk assessment conducted by Sanofi Pasteur in support of the initial biological license application for MenACYW-TT. METHODS...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Open Forum Infect Dis
Main Authors: Neveu, David, Kürzinger, Marie-Laure, Chen, Aiying, Dhingra, Mandeep S
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2020
Fag:
Poster Abstracts
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7776410/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa439.1428
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker